Goals of Cancer Immunotherapy

Article 1

GOALS OF CANCER IMMUNOTHERAPY

Immunotherapy is treatment that harnesses a person's immune system to fight diseases such as cancer, by doing one or more of the following:

  • Stimulating the existing immune system to more effectively to attack cancer cells
  • Supplementing the immune system with necessary components, such as man-made cytokines or specially engineered T cells
  • Preventing cancer cells from dampening immune responses

Most immunotherapy approaches focus on leveraging the adaptive immune system and using it as a tool against cancer. This is based on 2 key features of the adaptive immune system.

  • First, the diversity of receptors in the adaptive immune system offers a capacity for target specificity—greater than that of any synthetic drug library.
  • Second, the cell-killing weaponry of the adaptive immune system and its ability to recruit additional cells of the innate immune system, when needed, offer the potential to kill any cell, once it is recognized.

By leveraging these mechanisms, the goal of cancer immunotherapy is to initiate or reinitiate a self-sustaining cycle of cancer immunity. This should amplify and propagate, while not generating uncontrolled autoimmune inflammatory responses. This gives a long duration of response. Examples of immunotherapies include:

  • Cancer vaccines
  • Chimeric antigen receptor (CAR) T-cell therapy
  • Tumor-infiltrating lymphocyte (TIL) therapy
  • Anti-CTLA-4 antibodies
  • Anti-PD-1 and anti-PD-L1 antibodies
  • Interleukin-2 (IL-2)
  • Interferon-alpha (IFN-α)

The potential effects of these and other therapies on the cancer immunity cycle are reviewed in the figure.

For more information on Cancer Immunotherapy, select the video icon below.